Amedisys Inc (STU:ADY)
€ 87 0 (0%) Market Cap: 2.90 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.87 GF Score: 85/100

Q3 2019 Amedisys Inc Earnings Call Transcript

Oct 30, 2019 / 03:00PM GMT
Release Date Price: €115 (-4.17%)
Operator

Greetings. Welcome to the Amedisys Third Quarter 2019 Earnings Conference Call. (Operator Instructions) Please note, this conference is being recorded.

At this time, I'll turn the conference over to Nick Muscato, Vice President of Strategic Finance. Nick, you may begin.

Nick Muscato
Amedisys, Inc. - VP of Strategic Finance

Thank you, operator, and welcome to the Amedisys investor conference call to discuss the results of our third quarter ended September 30, 2019. A copy of our press release, supplemental slides and related Form 8-K filings with the SEC are available on the Investor Relations page of our website.

Speaking on today's call from Amedisys will be Paul Kusserow, Chief Executive Officer; and Scott Ginn, Chief Financial Officer. Also joining us is Chris Gerard, Chief Operating Officer; and Dave Kemmerly, General Counsel and Senior Vice President of Government Affairs.

Before we get started with our call, I would like to remind everyone that statements made on this conference call today may constitute forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot